Epigenetic modification of mir-217 promotes intervertebral disc degeneration by targeting the fbxo21-erk signalling pathway

HIGHLIGHTS

• who: Zhonghui Chen from the Renmin Hospital of Wuhan University, No, ZhangZhiDong Street, Wuchang District, Wuhan, Hubei, China have published the research: Epigenetic modification of miR-217 promotes intervertebral disc degeneration by targeting the FBXO21-ERK signalling pathway, in the Journal: (JOURNAL)
• what: Trial registration: This study was performed in strict accordance with the NIH guidelines for the care and use of laboratory animals (NIH Publication No 85-23 Rev. 1985) and was approved by the human research ethics committee of Wuhan University Renmin Hospital (Approval No RMHREC-D-2020-391) and written informed consent . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.